These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27163830)

  • 1. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study.
    Zeydan B; Lowe VJ; Tosakulwong N; Lesnick TG; Senjem ML; Jack CR; Fields JA; James TT; Gleason CE; Dowling NM; Miller VM; Kantarci K
    Neuroreport; 2021 Mar; 32(4):326-331. PubMed ID: 33470769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on brain structure: A randomized controlled trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Gunter JL; Gleason CE; Wharton W; Dowling NM; Vemuri P; Senjem ML; Shuster LT; Bailey KR; Rocca WA; Jack CR; Asthana S; Miller VM
    Neurology; 2016 Aug; 87(9):887-96. PubMed ID: 27473135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
    Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
    Files JA; Miller VM; Cha SS; Pruthi S
    J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
    El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
    Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
    J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.
    Silverman DH; Geist CL; Kenna HA; Williams K; Wroolie T; Powers B; Brooks J; Rasgon NL
    Psychoneuroendocrinology; 2011 May; 36(4):502-13. PubMed ID: 20810219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
    Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
    Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
    Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
    Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
    Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
    Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
    Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.